Mark T. Friedman

ORCID: 0000-0001-7326-1357 · 1 paper in corpus

nonrandomized-trial 2023

Phase II Study of Danazol with Plasma Exchange and Corticosteroids for the Treatment of Thrombotic Thrombocytopenic Purpura

·doi:10.1182/blood-2023-178552

Background: Ahn and colleagues reported a decrease in plasma exchange (PE)/plasma infusion requirement with danazol in seven cases of thrombotic thrombocytopenic purpura (TTP) (Ahn Blood 2006;108(11):1057a). We reported an increase in plate…